ECL vs TERN · P/E 35, rev $4.01B vs $6.12B cap
Ecolab Inc (ECL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ECL and TERN stock pages for the full models.
Not investment advice.